Results 161 to 170 of about 700,500 (193)

To mix or not to mix? A rapid systematic review of heterologous prime-boost covid-19 vaccination. [PDF]

Expert Rev Vaccines, 2021
Chiu NC, Chi H, Tu YK, Huang YN, Tai YL, Weng SL, Chang L, Huang DT, Huang FY, Lin CY.   +9 more
europepmc   +1 more source

The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings. [PDF]

JCI Insight, 2022
Valeri V, Sochon A, Cousu C, Chappert P, Lecoeuche D, Blanc P, Weill JC, Reynaud CA.   +7 more
europepmc   +1 more source

Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population. [PDF]

Vaccine X, 2023
Tabatabaeifar S, Vestergaard JM, Würtz ET, Hansen KK, Nielsen KJ, Schlünssen V, Kolstad HA.   +6 more
europepmc   +1 more source

Heterologous prime-boost immunization based on a human adenovirus 5 vectored containing Trichinella spiralis Cystatin-like protein elicits protective mucosal immunity in mice. [PDF]

PLoS Negl Trop Dis
Xu N, Wang Y, Xu N, Xiang Z, Wang D, Yu Y, Liu M, Liu X, Tang B, Bai X.   +9 more
europepmc   +1 more source

Heterologous prime-boost immunization of two-component vaccine candidate PWDVax protected pigs against F18 enterotoxigenic <i>Escherichia coli</i> post-weaning diarrhea. [PDF]

Infect Immun
Zhang C, Li S, Upadhyay I, Vakamalla SSR, Lauder KL, Hansen C, Massey KA, Hayes C, Herndon NL, Zhang W.   +9 more
europepmc   +1 more source

Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice. [PDF]

Sci Transl Med
Cottrell CA, Hu X, Lee JH, Skog P, Luo S, Flynn CT, McKenney KR, Hurtado J, Kalyuzhniy O, Liguori A, Willis JR, Landais E, Raemisch S, Chen X, Baboo S, Himansu S, Diedrich JK, Duan H, Cheng C, Schiffner T, Bader DLV, Kulp DW, Tingle R, Georgeson E, Eskandarzadeh S, Alavi N, Lu D, Sincomb T, Kubitz M, Mullen TM, Yates JR, Paulson JC, Mascola JR, Alt FW, Briney B, Sok D, Schief WR.   +36 more
europepmc   +1 more source

Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. [PDF]

Vaccine X
Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J.   +9 more
europepmc   +1 more source

Heterologous Prime-Boost COVID-19 Vaccination: Initial Reactogenicity Data [PDF]

Lancet, The, 2021
Matthew D Snape, Xinxue Liu, Jonathan S Nguyen Van-Tam   +2 more
exaly   +5 more sources

Heterologous Prime-Boost: Breaking the Protective Immune Response Bottleneck of COVID-19 Vaccine Candidates

Emerging Microbes and Infections, 2021
COVID-19 vaccines emerging from different platforms differ in efficacy, duration of protection, and side effects. To maximize the benefits of vaccination, we explored the utility of employing a heterologous prime-boost strategy in which different ...
Cui Bopei, Miao Xu, Zhenglun Liang
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

A prime–boost vaccination of mice with heterologous H5N1 strains

Vaccine, 2009
We evaluated the priming effect of an H5N1 pandemic vaccine in a mouse model to investigate strategies for influenza pandemic vaccination. For priming, an alum-adjuvanted inactivated whole H5N1 vaccine (NIBRG-14, clade 1) was used. As booster vaccines, several formulations of Indo05/05/2005(H5N1)PR8-IBCDC-RG2 vaccines (clades 2-1)were evaluated ...
Daisuke, Ikeno, Kazuhiko, Kimachi, Yasuhiro, Kudo, Shuro, Goto, Shigeyuki, Itamura, Takato, Odagiri, Masato, Tashiro, Yoichiro, Kino   +7 more
openaire   +2 more sources